Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold.
Journal
The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125
Informations de publication
Date de publication:
01 Dec 2020
01 Dec 2020
Historique:
pubmed:
12
9
2020
medline:
15
12
2020
entrez:
11
9
2020
Statut:
ppublish
Résumé
To evaluate intrafractional fiducial marker position variations during stereotactic body radiotherapy (SBRT) in patients treated for liver metastases in visually guided, voluntary deep inspiration breath-hold (DIBH). 10 patients with implanted fiducial markers were studied. Respiratory coaching with visual guidance was used to ensure comfortable voluntary breath-holds for SBRT imaging and delivery. Three DIBH CTs were acquired for treatment planning. Pre- and post-treatment CBCTs were acquired for each of the three treatment fractions. Per-fraction marker position was evaluated on planar 2D kV images acquired during treatment fractions for 4 of the 10 patients. The median difference in marker position was 0.3 cm (range, 0.0-0.9 cm) between the three DIBH CTs and 0.3 cm (range, 0.1 to 1.4 cm) between pre- and post-treatment CBCTs. The maximum intrafractional variation in marker position in craniocaudal (CC) direction on planar kV images was 0.7 to 1.3 cm and up to 1.0 cm during a single DIBH. Difference in marker position of up to 1.0 cm was observed during a single DIBH despite use of narrow external gating window and visual feedback. Stability examination on pre-treatment DIBH CTs was not sufficient to guarantee per-fraction stability. Evaluation of differences in marker position on pre- and post-treatment CBCT did not always reveal the full magnitude of the intrafractional variation. To increase treatment accuracy, it is necessary to apply real-time monitoring of the tumour or a reliable internal surrogate when delivering liver SBRT in voluntary DIBH.
Identifiants
pubmed: 32915653
doi: 10.1259/bjr.20200859
pmc: PMC7716004
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20200859Références
Med Phys. 2007 Sep;34(9):3620-9
pubmed: 17926966
Radiother Oncol. 2017 Apr;123(1):78-84
pubmed: 28245908
Phys Med Biol. 2018 Jul 16;63(14):145010
pubmed: 29923837
Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):132-140
pubmed: 28490984
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1201-8
pubmed: 19386435
Phys Med Biol. 2011 Sep 7;56(17):5445-68
pubmed: 21813963
Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):302-8
pubmed: 19628342
Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):366-375
pubmed: 29559289
Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):190-7
pubmed: 23414764
Radiother Oncol. 2016 Oct;121(1):75-78
pubmed: 27555229
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1247-52
pubmed: 15990028
Adv Radiat Oncol. 2018 Aug 23;4(1):142-149
pubmed: 30706022
Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1410-21
pubmed: 11728702
Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1573-83
pubmed: 20399034
Br J Radiol. 2016 Dec;89(1068):20160544
pubmed: 27706950
Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):751-9
pubmed: 16458774
J Appl Clin Med Phys. 2018 Jan;19(1):39-45
pubmed: 29152835
Radiat Oncol. 2019 Jun 3;14(1):93
pubmed: 31159840
Radiother Oncol. 2018 Feb;126(2):339-346
pubmed: 28992962
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):297-304
pubmed: 18406894
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):630-8
pubmed: 17236980
Strahlenther Onkol. 2020 Aug;196(8):691-698
pubmed: 32002567
Med Phys. 2012 Oct;39(10):6431-42
pubmed: 23039678
Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):907-15
pubmed: 18514783
Radiother Oncol. 2018 Dec;129(3):441-448
pubmed: 30033386
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):478-92
pubmed: 26867877
Acta Oncol. 2017 Jun;56(6):860-866
pubmed: 28464747
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):610-9
pubmed: 16966004
Phys Med. 2019 Sep;65:46-52
pubmed: 31430586